Evidence map›Paper›PMID 37917755›Full record

ArticlePloS one2023

Comparative genome analysis of colistin-resistant Escherichia coli harboring mcr isolated from rural community residents in Ecuador and Vietnam.

Hoa Thi Thanh Hoang, Mayumi Yamamoto, Manuel Calvopina, Carlos Bastidas-Caldes, Diep Thi Khong, Thang Nam Nguyen, Ryuji Kawahara, Takahiro Yamaguchi, Yoshimasa Yamamoto

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Molecular detection and prevalence of colistin-resistant Escherichia coli in poultry and humans: a one health perspective.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2025
    Article
  2. Article
  3. Article
  4. Detection of mobile colistin resistance genesMicrobiology resource announcements · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Hoa Thi Thanh HoangUnited Graduate School of Drug Discovery and Medical Information Sciences, Gifu University, Gifu, Japan.ORCID 0009-0002-5304-0607
Mayumi YamamotoUnited Graduate School of Drug Discovery and Medical Information Sciences, Gifu University, Gifu, Japan.ORCID 0000-0002-5603-6825
Manuel CalvopinaOne Health Research Group, Universidad De Las Americas, Quito, Ecuador.
Carlos Bastidas-CaldesOne Health Research Group, Universidad De Las Americas, Quito, Ecuador.ORCID 0000-0002-5364-7700
Diep Thi KhongCenter for Medical and Pharmaceutical Research and Service, Thai Binh University of Medicine and Pharmacy, Thai Binh, Vietnam.
Thang Nam NguyenCenter for Medical and Pharmaceutical Research and Service, Thai Binh University of Medicine and Pharmacy, Thai Binh, Vietnam.
Ryuji KawaharaDepartment of Microbiology, Osaka Institute of Public Health, Osaka, Japan.
Takahiro YamaguchiDepartment of Microbiology, Osaka Institute of Public Health, Osaka, Japan.
Yoshimasa YamamotoUnited Graduate School of Drug Discovery and Medical Information Sciences, Gifu University, Gifu, Japan.ORCID 0000-0002-2942-1672
Gifu University · JPOsaka Prefectural Institute of Public Health · JPThai Binh University of Medicine and Pharmacy · VNUniversidad de Las Américas · EC

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The spread of colistin-resistant bacteria among rural community residents of low- and middle-income countries is a major threat to community health. Although the mechanism of the spread of colistin-resistant bacteria in communities is unknown, geographic and regional characteristics may influence it. To elucidate the spread mechanism of colistin-resistant bacteria, we analyzed the genomes of colistin-resistant Escherichia coli isolated from Vietnam and Ecuador residents, which are geographically and socially different. Stool specimens of 139 and 98 healthy residents from Ecuador and Vietnam rural communities, respectively, were analyzed for colistin-resistant E. coli with mcr. Its prevalence in the residents of all the communities assessed was high and approximately equal in both countries: 71.8% in Ecuador and 69.4% in Vietnam. A phylogenetic tree analysis revealed that the sequence type of colistin-resistant E. coli was diverse and the major sequence types were different between the two countries. The location of mcr in the isolates showed that the proportion of chromosomal mcr was 35.1% and 8.5% in the Vietnam and Ecuador isolates, respectively. Most of these chromosomal mcr genes (75%-76%) had an intact mcr-transposon Tn6330. Contrastingly, the replicon types of the mcr-carrying-plasmids were diverse in both countries, but almost all belonged to IncI2 in Ecuador and IncX1/X4 in Vietnam. Approximately 26%-45% of these mcr-plasmids had other resistance genes, which also varied between countries. These results suggest that although the overall profile of the colistin-resistant E. coli isolates is diverse in these countries, the phylogenesis of the isolates and mcr-carrying plasmids has regional characteristics. Although the contributing factors are not clear, it is obvious that the overall profile of colistin-resistant bacteria dissemination varies between countries. Such different epidemic patterns are important for establishing country-specific countermeasures against colistin-resistant bacteria.

Indexed as

ColistinEscherichia coli ProteinsAnti-Bacterial AgentsDrug Resistance, BacterialEcuadorEscherichia coliHumansMicrobial Sensitivity TestsPhylogenyPlasmidsRural PopulationVietnamAnti-Bacterial AgentsColistinEscherichia coli Proteins

Identifiers

PMID37917755
PMCPMC10621974
OpenAlexW4388214992

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.